全文获取类型
收费全文 | 964093篇 |
免费 | 58749篇 |
国内免费 | 1095篇 |
专业分类
耳鼻咽喉 | 12691篇 |
儿科学 | 31916篇 |
妇产科学 | 25092篇 |
基础医学 | 158273篇 |
口腔科学 | 25398篇 |
临床医学 | 84077篇 |
内科学 | 177847篇 |
皮肤病学 | 22655篇 |
神经病学 | 67195篇 |
特种医学 | 35349篇 |
外国民族医学 | 116篇 |
外科学 | 142937篇 |
综合类 | 15844篇 |
现状与发展 | 2篇 |
一般理论 | 222篇 |
预防医学 | 71762篇 |
眼科学 | 22784篇 |
药学 | 74735篇 |
1篇 | |
中国医学 | 2044篇 |
肿瘤学 | 52997篇 |
出版年
2018年 | 10019篇 |
2016年 | 8380篇 |
2015年 | 9337篇 |
2014年 | 12630篇 |
2013年 | 19143篇 |
2012年 | 27043篇 |
2011年 | 29584篇 |
2010年 | 17189篇 |
2009年 | 15845篇 |
2008年 | 27717篇 |
2007年 | 30110篇 |
2006年 | 29897篇 |
2005年 | 28516篇 |
2004年 | 27829篇 |
2003年 | 26742篇 |
2002年 | 26041篇 |
2001年 | 43396篇 |
2000年 | 44855篇 |
1999年 | 36938篇 |
1998年 | 10015篇 |
1997年 | 8553篇 |
1996年 | 8855篇 |
1995年 | 8240篇 |
1994年 | 7519篇 |
1992年 | 27843篇 |
1991年 | 29032篇 |
1990年 | 29161篇 |
1989年 | 28317篇 |
1988年 | 26016篇 |
1987年 | 25765篇 |
1986年 | 24185篇 |
1985年 | 23163篇 |
1984年 | 17283篇 |
1983年 | 14713篇 |
1982年 | 8041篇 |
1981年 | 7362篇 |
1979年 | 16697篇 |
1978年 | 12018篇 |
1977年 | 9916篇 |
1976年 | 9967篇 |
1975年 | 11688篇 |
1974年 | 13501篇 |
1973年 | 12979篇 |
1972年 | 12209篇 |
1971年 | 11752篇 |
1970年 | 10935篇 |
1969年 | 10370篇 |
1968年 | 9784篇 |
1967年 | 8773篇 |
1966年 | 7831篇 |
排序方式: 共有10000条查询结果,搜索用时 22 毫秒
61.
Pankaj Dabir Snehal Dabir B V Siva Prasad M V R Reddy 《Infection, genetics and evolution》2006,6(4):287-291
Molecular characterization of Wuchereria bancrofti is essential to develop suitable anti-filarial drugs and vaccines. We describe here isolation, sequence analysis and cloning of a partial cDNA of an enzyme superoxide dismutase from this parasite. The immunoscreening of a lambda zap W. bancrofti microfilarial (Mf) cDNA library with microfilaremic sera had resulted in the isolation of several seroreactive clones including, WbSOD. This clone contained a 309 bp insert and showed significant nucleotide and deduced amino acid sequence homologies to the superoxide dismutases of other nematode parasites. The antioxidant property of this enzyme may have important contribution in the defense mechanism of the parasite against host immune response. 相似文献
62.
63.
64.
65.
66.
AIMS: To examine the effects of agents that alter potassium adenosine triphosphate (KATP) channel activity in beta-cells on cognitive function and counterregulatory hormone responses during acute hypoglycaemia, given the physiological similarities between the pancreatic beta-cell and the hypothalamic glucose-sensitive neurones (GSN) and the widespread distribution of sulphonylurea receptors in neuronal cells throughout the brain. METHODS: Ten healthy males were studied on four occasions and in random order underwent three stepped hypoglycaemic (plasma glucose aims: 3.4, 2.8, 2.4 mmol/l) and one euglycaemic (plasma glucose aim: 5 mmol/l) insulin clamps. Prior to each hypoglycaemic study, volunteers received either 10 mg glibenclamide, or 5 mg/kg diazoxide or placebo orally. Cognitive function, symptom scores and counterregulatory hormone responses were measured at each glycaemic level. RESULTS: There was no statistically significant effect of either drug on the symptoms generated or the counterregulatory hormonal response during hypoglycaemia. However, cognitive function was better preserved during hypoglycaemia in the glibenclamide-treated arm, particularly four-choice reaction time which deteriorated at a plasma glucose 2.5 mmol/l compared with 3.0 mmol/l with diazoxide (P = 0.015) and 2.9 mmol/l with placebo (P = 0.114). CONCLUSIONS: Single doses of pharmacological agents which alter membrane KATP channel activity do not affect the counterregulatory response to hypoglycaemia but may modify cognitive function during cerebral glucopenia. The unexpected effects of glibenclamide on cortical function suggest a novel action of sulphonylureas that warrants further investigation. 相似文献
67.
P F Plouin D L Clement H Boccalon J Dormandy I Durand-Zaleski G Fowkes L Norgren T Brown 《International angiology》2003,22(4):333-339
Atherosclerotic renal artery stenosis (ARAS) may cause hypertension, progressive renal failure, and recurrent pulmonary edema. It typically occurs in high risk patients with coexistent vascular disease elsewhere. Most patients with ARAS are likely to die from coronary heart disease or stroke before end-stage renal failure occurs. Recent controlled trials have shown that most patients undergoing angioplasty to treat renovascular hypertension still need antihypertensive agents 6 or 12 months after the procedure. Nevertheless, the number of antihypertensive agents required to control blood pressure adequately is lower following angioplasty than for medication alone. Trials assessing the value of revascularization for preserving renal function or preventing clinical events are only in the early recruitment phase. Revascularization should be undertaken in patients with ARAS and resistant hypertension or heart failure, and probably in those with rapidly deteriorating renal function or with an increase in plasma creatinine levels during angiotensin-converting enzyme inhibition. With or without revascularization, medical therapy using antihypertensive, hypolipidemic and antiplatelet agents is necessary in almost all cases. 相似文献
68.
OBJECTIVE: This study was conducted to compare an otolaryngologist's experience with a cohort of epilepsy patients implanted with a vagal nerve stimulator (VNS) to previously published data. METHODS: Demographics, preoperative seizure frequency, medications, and complications were retrospectively collected from patients implanted by the senior author. Postoperative medications and seizure frequency were obtained from referring neurologists. RESULTS: Seventeen patients were implanted over a 24-month period. Average age was 28.3 years. Patients presented with petit mal (n = 3), tonic-clonic (n = 6), complex partial (n = 5), and grand mal (n = 8) seizures. Mean follow-up postimplantation was 13.5 months. Most patients had at least a 50% reduction of seizure frequency, with 3 patients being seizure free. There were no postoperative infections. One patient had left vocal cord immobility. The most common side effect was voice disturbance during device activation. CONCLUSION: Otolaryngologists are well equipped to perform VNS implantation and to diagnose and treat possible laryngeal side effects. EBM rating: C-4. 相似文献
69.
S. V. Terent’eva E. N. Komarova T. N. Sapozhnikova A. T. Teplyakov E. A. Ivanovskaya T. I. Andreeva 《Pharmaceutical Chemistry Journal》2006,40(12):694-696
A rapid procedure for determining angiotensin II in the blood by inverse voltammetry using a TA-2 device (Tekhnoanalit Company,
Tomsk) with a graphite electrode has been developed. The results of analyses using the proposed technique agree with the clinical
data. The rapid analytical procedure favors optimization of cardiotropic drug therapy.
__________
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 40, No. 12, pp. 54–56, December, 2006. 相似文献
70.